FOLLOW US

America October 28, 2026 7 mins read

Pentagon Ketamine Contract: $41M Deal Under Fire

America ı By Michallie K Harrison

0 Comments

Pentagon ketamine contract editorial illustration showing the Pentagon, symbolic medication wafers and pharmaceutical manufacturing equipment.

Key Takeaways

  • A $40.95 million sole-source award funds development. Announced in February, the 36-month contract supports Wafermine’s clinical development and pursuit of emergency authorization. The award amount does not establish how much has been paid.
  • Ketamine already has a battlefield role. Military research documents its growing use for combat casualties. Wafermine introduces a different delivery method: a wafer that dissolves under the tongue.
  • The emergency declaration does not authorize Wafermine. The federal notice opens a regulatory pathway; a separate FDA decision is required.
  • Manufacturing readiness remains unresolved. October reporting identified a Nevada licensing obstacle involving the proposed U.S. manufacturing partner. That does not establish that troops received improperly manufactured medicine.

WASHINGTON — The Pentagon has awarded a Singapore-based pharmaceutical company nearly $41 million to develop ketamine wafers for wounded troops, pursuing a treatment that could reach the battlefield through emergency authorization before full Food and Drug Administration approval.

The sole-source development award to iX Biopharma supports Wafermine, a drug designed to dissolve under the tongue and treat moderate to severe acute pain.

But the effort faces questions about manufacturing readiness. Defense News reported Oct. 22, citing a Politico investigation, that the company’s proposed U.S. manufacturing partner lacked the Nevada license required to operate.

The public record describes a development program with regulatory and production steps still ahead. Its significance lies in both the medical need it seeks to address and the government’s responsibility to establish that the treatment can be safely manufactured, authorized and delivered.

What the $41 million Pentagon ketamine contract covers

iX Biopharma disclosed the $40.95 million award Feb. 12. The 36-month program, funded through the Defense Health Agency Contracting Activity, supports clinical development and work toward emergency authorization.

The company attributed its sole-source selection to its technology, development progress and ability to meet government requirements. Its announcement describes monthly payments and cost reimbursements; the award value is not a record of money already paid.

Sole-source contracting is permitted under specified circumstances. For example, federal acquisition rules allow awards without full and open competition when only one responsible source can satisfy an agency’s requirements, subject to justification and other conditions.

The company’s announcement does not establish which contracting authority governed this particular award or reproduce the Pentagon’s complete justification. Assessing the selection and price would require those government records. The absence of competitive bidding alone does not establish wrongdoing.

Why the military wants a wafer

Wafermine’s proposed advantage is its delivery method. The company says the wafer allows ketamine to enter the bloodstream through tissue under the tongue, avoiding the need for an injection or intravenous access.

That design addresses a problem the Defense Health Agency identifies in its battlefield pain program: providing rapid pain relief during field care and evacuation, including when casualties require prolonged treatment before reaching higher-level care.

The agency describes an effort to develop nonopioid medicines, including ketamine, suitable for those conditions. It also identifies an existing medication that can be administered without an IV, underscoring that Wafermine would enter an established field of battlefield pain treatments.

Whether this particular formulation offers sufficient benefits, and under what conditions it should be used, remains a question for clinical evidence and regulatory review.

Ketamine already has a battlefield role

The military’s use of ketamine predates this contract.

A study of Department of Defense Trauma Registry records examined 5,965 patients and 8,607 pain-medication administrations during U.S. military operations from 2010 through 2019.

Ketamine’s annual share of those administrations rose from 14.2% to 52.6%, while the opioid share declined from 85.8% to 47.4%. Among patients who received a single pain-medication dose, those given ketamine had more severe injuries on average.

The researchers described ketamine as an increasingly used treatment for combat casualties. Their retrospective analysis establishes experience with the drug, but it does not demonstrate that Wafermine itself is safe or effective.

Ketamine also has effects beyond pain relief. The study describes dose-dependent effects that can include dissociation and amnesia. The medical history supporting interest in the drug does not eliminate the need to evaluate a new formulation and its proposed use.

The emergency declaration opens a regulatory path

A federal notice published Sept. 3 provides the legal foundation for considering emergency battlefield pain treatments.

According to the notice, the Pentagon determined July 15 that a military emergency, or a significant potential for one, involved heightened risks to U.S. forces. Health and Human Services Secretary Robert F. Kennedy Jr. issued the corresponding declaration Aug. 31.

Its scope includes casualties associated with chemical, biological, radiological and nuclear agents, as well as conventional combat weapons, including firearms, projectiles and explosives. It addresses moderate to severe acute pain and risks such as shock and respiratory distress.

The notice does not name Wafermine, identify a specific impending operation or authorize a particular medication. It permits the FDA to consider individual emergency authorizations under the applicable statutory requirements.

Under FDA guidance on emergency use authorization, the agency must assess whether a product may be effective, whether its known and potential benefits outweigh its risks, and whether an adequate, approved and available alternative exists.

That evidentiary standard differs from full approval. The guidance also calls for information about manufacturing sites and their compliance with manufacturing requirements.

Nevada manufacturing remains a central issue

The proposed production arrangement involves Orion Specialty Labs LLC in Henderson, Nevada.

In a June 15 filing with the Singapore Exchange, iX Biopharma announced plans to move a freeze dryer, packaging line and other equipment from Croydon, Australia, to Orion’s facility.

The company said U.S. manufacturing was required to fulfill the government contract and described the move as a way to accelerate production.

State records document an earlier licensing obstacle. Nevada State Board of Pharmacy minutes from March show Orion’s outsourcing-facility application was tabled after testimony and questions from board members.

Those minutes establish what happened in March; they do not independently establish Orion’s current licensing status. The more recent assertion that the necessary license remained outstanding comes from the October reporting.

The commercial arrangement also remained unfinished in the company’s Oct. 10 shareholder update. iX Biopharma said it was still negotiating final terms for the proposed Orion joint venture.

These records leave questions about production readiness. They do not establish that troops have received improperly manufactured medicine or that a contractual delivery deadline has been missed.

Company filings give different submission windows

The company’s public statements also warrant a closer look at timing.

In its Sept. 7 announcement, iX Biopharma said it expected to complete its emergency-use application in the fourth quarter of 2026. It also described the possibility of military sales before full approval.

The Oct. 10 shareholder update used a broader window, saying the company anticipated completing the application within the next 12 months. It described preparatory studies as underway and an FDA meeting as a step preceding two planned Phase 3 trials.

The later statement does not explicitly withdraw the year-end target or announce a delay. Both windows could accommodate a submission this year. It nevertheless provides less precise guidance about when the application will be finished. Neither filing establishes that the FDA has authorized Wafermine.

Readiness depends on more than an award

The effort belongs within a broader discussion of how the military prepares to function when normal support becomes difficult. USA Herald’s reporting on FORTRESS America and wartime infrastructure disruption examines that problem at military installations. Battlefield medicine addresses the consequences for casualties when treatment and evacuation are constrained.

The contract and emergency declaration show government support for developing a new pain-treatment option. Establishing its operational value will require evidence about clinical performance, manufacturing readiness and delivery.

The outstanding records matter: the Pentagon’s contracting justification, payment and milestone information, an updated state licensing determination, and any FDA authorization specifying how the drug may be used.

For wounded service members, the practical measure of success will be whether the program delivers a dependable treatment that medical personnel can use safely under battlefield conditions.

Previous Article

Flávio Bolsonaro in Florida: Visa Approved, Extradition Unclear

Read More
156 Posts

Michallie K Harrison

Michallie K. Harrison is a journalist, communications professional, and retired U.S. Army sergeant first class with 21 years of service, including three combat tours. She covers politics, public policy, law, technology, and national security for USA Herald, with particular attention to government accountability, civil liberties, and the effects of policy on everyday Americans. Her military background brings firsthand experience in leadership, aviation operations, and chemical defense to her reporting on defense and veterans’ issues. Harrison holds a Bachelor of Arts in Communications from National University and a Bachelor of Arts in Liberal Studies from Excelsior College, with minors in history and criminal justice. Her work has appeared in Responsible Statecraft, and she writes about veterans’ benefits for Hill & Ponton. She also brings experience hosting live public affairs discussions and engaging a social media audience of nearly 200,000 followers. Harrison is committed to making complex issues understandable and asking direct questions about how power is exercised and whom it serves.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 17, 2026 Aon completes $17B acquisition of USI By – Rachel Moore
America November 17, 2026 Apple services, including iCloud and the App Store, hit by outage By – Rachel Moore
America November 17, 2026 classified US national security communications network goes down By – Rachel Moore
America November 17, 2026 Widespread Technology Disruption in Major Banks, Airlines and the Internet By – Jackie Allen
America November 17, 2026
Content Creator Chrisean Rock Faces Looming…

By Samuel Lopez – USA Herald INGLEWOOD, Calif. – What…

By – Samuel Lopez
America November 17, 2026
“Not the Wild West”: California Sues…

SAN FRANCISCO — California Attorney General Rob Bonta has sued…

By – Derek Johnson
America November 17, 2026
Voyager 1 Is About to Become…

PASADENA, Calif. — Forty-nine years after it left Earth atop…

By – Derek Johnson
Breaking News November 17, 2026
Putin’s Prized Crimean Bridge Collapses Into…

KYIV, Ukraine — A section of the Kerch Bridge, the…

By – Derek Johnson
America November 17, 2026
Optimizely Hack Turns Trusted Websites Into…

An Optimizely hack exposed visitors to malicious code through website…

By – Michallie K Harrison
America November 16, 2026
Iran Dirty Bomb Report Sparks U.S.…

WASHINGTON — An Iran dirty bomb report describes U.S. contingency…

By – Michallie K Harrison
America November 16, 2026
FBI Investigates Explosive Device at Illinois…

PEORIA, Illinois — Federal authorities are investigating an explosive device…

By – Jackie Allen
America November 16, 2026
MIT Sues Microsoft Over Quantum Security…

By Samuel LĂłpez | USA Herald Massachusetts Institute of Technology…

By – Samuel Lopez
America November 16, 2026
Sneaker Wave Nearly Sweeps Oregon Woman…

SECRET BEACH, Oregon — A peaceful day along Oregon’s rugged…

By – Jackie Allen
America November 16, 2026
Bank Outages Hit After FAA and…

WASHINGTON – Millions of Americans have experienced disruptions to essential…

By – Samuel Lopez
America November 16, 2026
Robert Pattinson Named New James Bond:…

LONDON — Robert Pattinson has been named the newest actor…

By – Jackie Allen
America November 16, 2026
Mystery Star System Transmits Radio Signals…

PERTH, Australia — Astronomers have discovered an unusual star system…

By – Jackie Allen
America November 16, 2026
U.S. Soldiers Googled Hospitals After Deadly…

WASHINGTON — U.S. soldiers used Google to find hospitals after…

By – Michallie K Harrison
America November 16, 2026
Musk’s xAI Chemical Spill Triggers Mississippi…

SOUTHAVEN, Miss. — An xAI chemical spill released an estimated…

By – Michallie K Harrison
America November 16, 2026
Billions for FAA Upgrades. Why Did…

WASHINGTON — Congress approved billions for FAA upgrades before a…

By – Michallie K Harrison
America November 16, 2026
Texas Man Executed for Beheading Three…

HUNTSVILLE, Texas — A 46-year-old Texas man convicted of murdering…

By – Jackie Allen
America November 15, 2026
Roseville Home Shooting: Two Found Dead…

The Roseville home shooting began as a call that sounded…

By – Rachel Moore
America November 15, 2026
Trump’s Golf Course Renovation Blocking: Federal…

The fight over Trump’s golf course renovation blocking just hit…

By – Rachel Moore
America November 16, 2026
“Bring Jensen Back”: Elon Musk and…

SANTA CLARA, Calif. — Just days after Jensen Huang resigned…

By – Derek Johnson
America November 15, 2026
S.C. Man Sentenced to Life in…

MYRTLE BEACH, S.C. — A South Carolina man has been…

By – Jackie Allen
America November 15, 2026
UPS and Copa Airlines Planes Collide…

The moment the UPS and Copa Airlines planes collided at…

By – Tyler Brooks
America November 15, 2026
FAA Ground Stop: Duffy Refuses to…

The FAA ground stop left hundreds of thousands of travelers…

By – Tyler Brooks
America November 15, 2026
Advent to Acquire Vermeg: Private Equity…

The news that Advent is set to acquire Vermeg puts…

By – Tyler Brooks
America November 15, 2026
The Orange County School Board approves…

Many Orange County Public Schools employees walked into Friday’s meeting…

By – Tyler Brooks
America November 15, 2026
America Loses Its Measles-Free Status for…

WASHINGTON, D.C. — For the first time in a quarter…

By – Derek Johnson
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 11, 2026
AI Godfather Warns of Chernobyl-Style Blackout…

By Samuel LĂłpez | USA Herald | November 11, 2026…

By – Samuel Lopez
America November 10, 2026
Vitamin K Deficiency Bleeding: Why the…

A single injection administered in the first hours of life…

By – Tyler Brooks
America November 10, 2026
Infant Bleeding Surges as Vitamin K…

Infant bleeding rose as fewer newborns received vitamin K shots,…

By – Michallie K Harrison
America November 15, 2026
Tower Hill Investment in Gator Athletics:…

The Tower Hill investment in Gator Athletics just rewrote the…

By – Tyler Brooks
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen
America November 4, 2026
WNBA: DeWanna Bonner Makes Emotional Admission…

ATLANTA — The WNBA Finals ended in heartbreak for the…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter